Respiratorius is a research company focused on the development of drug candidates for the treatment of cancer and especially aggressive lymphoma. The company was originally established in 1999 as a spin-off from Lund University. The business is located in Sweden, where research is conducted in-house but also through international partners. The company is headquartered in Lund.
CEO
Chairperson of the Board
Board
| Name | Capital % | Votes % | Date |
|---|---|---|---|
| Christer Fåhraeus | 11,24 | 11,24 | 2022-06-28 |
| Avanza Pension | 4,84 | 4,84 | 2023-03-29 |
| Valcuria Holding AB | 3,86 | 3,86 | 2023-03-29 |
| Ben Hayes | 2,34 | 2,34 | 2023-03-29 |
| Hans Harvig | 1,72 | 1,72 | 2023-03-29 |
| Benny Bengtsson | 1,09 | 1,09 | 2023-03-29 |
| Göran Lennart Rehn | 0,99 | 0,99 | 2023-03-29 |
| Hartmut Wiese | 0,99 | 0,99 | 2023-03-29 |
| Christian Müller | 0,95 | 0,95 | 2023-03-29 |
| Hans Mandahl | 0,86 | 0,86 | 2023-03-29 |
2023-08-08 Delårsrapport 2023-Q2
2023-11-14 Delårsrapport 2023-Q3
2024-02-13 Bokslutskommuniké 2023